Human Mdm2: A new molecular link to late-stage metastatic breast cancer

(Journal of Clinical Investigation) A large proportion of late-stage breast cancers that have spread to other parts of the body (metastatic breast cancers) are characterized by overexpression of the protein Mdm2. Researchers have now determined what drives this increased Mdm2 expression and found that Mdm2 helps promote cancer cells take on more aggressive characteristics, making it a potential target for drugs to treat late-stage metastatic breast cancer.

source : www.eurekalert.org

Related News:

• How Cells Protect Themselves From Cancer
• The optimal Rx for pancreatic cancer: Stop it before it starts
• Final-phase trial underway for everolimus in gastric cancer
• Pfizer Hid Evidence That HRT Causes Cancer
• Vitamin D May Help Prevent Colon Cancer
• The Human Brain: Exploring Status Quo Bias
• Treating Back Pain In Blood Marrow Cancer Patients
• Gaps Remain in Cancer Palliative Care
• Testicular Cancer Treatments Worse than the Disease
• Charlotte Gerson talks out about the cancer industry and natural cancer remedies